Scientists at the Brain Research Centre and the Centre for Molecular Medicine and Therapeutics at CFRI have uncovered a key cellular mechanism that alters brain cell function in Huntington's disease, and identified a possible treatment for the disease. The results of the study were published online today and will appear in the January 28 edition of the journal Neuron. Dr. Michael Hayden co-authored the study.

[news release]